BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7981362)

  • 1. [Favorable response to vinblastine in an idiopathic case of Evans Syndrome].
    Guerrero Becerra MP; Kessler Saiz P; Ortiz Conde MC; Fernández Miranda C
    An Med Interna; 1994 Jul; 11(7):341-4. PubMed ID: 7981362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effective danazol therapy for a patient with Evans syndrome].
    Koike M; Ishiyama T; Saito K; Osawa H; Hashimoto M; Wakabayashi Y; Tsuruoka N
    Rinsho Ketsueki; 1993 Feb; 34(2):143-6. PubMed ID: 8492411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged remission after splenectomy for refractory Evans syndrome--a case report and literature review.
    Hamidah A; Thambidorai CR; Jamal R
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):762-4. PubMed ID: 16124452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consolidation treatment with rituximab induces complete and persistent remission of mixed type Evans syndrome.
    Rodella E; Pacquola E; Bianchini E; Ramazzina E; Paolini R
    Blood Coagul Fibrinolysis; 2008 Jun; 19(4):315-8. PubMed ID: 18469554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic thrombopenic purpura associated with an autoimmune hemolytic anemia or Fisher-Evans syndrome: apropos of a case].
    Ndiaye O; Sylla A; Ndiaye FS; Diagne I; Diallo-Chauvin M; Diouf S; Sallm G; Kuakuvi K
    Dakar Med; 1999; 44(2):240-2. PubMed ID: 11957294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab for refractory Evans syndrome and other immune-mediated hematologic diseases.
    Mantadakis E; Danilatou V; Stiakaki E; Kalmanti M
    Am J Hematol; 2004 Nov; 77(3):303-10. PubMed ID: 15495242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of Evan's syndrome in pregnancy refractory to primary treatment options.
    Boren T; Reyes C; Montenegro R; Raimer K
    J Matern Fetal Neonatal Med; 2007 Nov; 20(11):843-5. PubMed ID: 17943645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful use of rituximab in Evans syndrome and refractory immune thrombocytopenic purpura.
    Kashif M; Qureshi A; Adil SN; Khurshid M
    J Pak Med Assoc; 2010 Jan; 60(1):64-5. PubMed ID: 20055286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
    Erdozain JG; Ruiz-Irastorza G; Egurbide MV; Aguirre C
    Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evans' syndrome: a retrospective study from the ship (French Society of Pediatric Hematology and Immunology) (36 cases)].
    Blouin P; Auvrignon A; Pagnier A; Thuret I; Antoni G; Bader-Meunier B; Le Deist F; Chastagner P; Aladjidi N; Pellier I; Bertrand Y; Behar C; Landmann-Parker J; Leverger G; Perel Y
    Arch Pediatr; 2005 Nov; 12(11):1600-7. PubMed ID: 16185853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab therapy for childhood Evans syndrome.
    Bader-Meunier B; Aladjidi N; Bellmann F; Monpoux F; Nelken B; Robert A; Armari-Alla C; Picard C; Ledeist F; Munzer M; Yacouben K; Bertrand Y; Pariente A; Chaussé A; Perel Y; Leverger G
    Haematologica; 2007 Dec; 92(12):1691-4. PubMed ID: 18055994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effective cyclosporine therapy to resistant-Evans syndrome].
    Tsudo M; Moriguchi T
    Rinsho Ketsueki; 1996 Nov; 37(11):1289-92. PubMed ID: 8960663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation.
    Urban C; Lackner H; Sovinz P; Benesch M; Schwinger W; Dornbusch HJ; Moser A
    Eur J Haematol; 2006 Jun; 76(6):526-30. PubMed ID: 16529601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of Evans syndrome post liver transplant with splenectomy and switch from tacrolimus to cyclosporine.
    Domenech C; Mialou V; Galambrun C; Lachaux A; Mure P; Dijoud F; Bertrand Y
    Transpl Int; 2008 Apr; 21(4):397-9. PubMed ID: 18167150
    [No Abstract]   [Full Text] [Related]  

  • 16. Two cases of refractory warm autoimmune hemolytic anemia treated with rituximab.
    Ramanathan S; Koutts J; Hertzberg MS
    Am J Hematol; 2005 Feb; 78(2):123-6. PubMed ID: 15682420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of a patient with mixed warm and cold antibody mediated Evans syndrome and glucose intolerance.
    Jubinsky PT; Rashid N
    Pediatr Blood Cancer; 2005 Sep; 45(3):347-50. PubMed ID: 15704210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal management, including precisely targeted irradiation, in a severe refractory case of Evans syndrome.
    Miale TD; Wong JY; Ahmed I; Wagman LD
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):726-8. PubMed ID: 16933267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
    Narat S; Gandla J; Hoffbrand AV; Hughes RG; Mehta AB
    Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.